Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

University of Texas Health Science Center at Houston

Headquarters: Houston, TX, United States of America
Year Founded: 1972
Status: Non-biopharma

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | Aug 27, 2024
Management Tracks

Patel joins Sana as EVP, CSO

Plus: Ian Clements named CFO of Marea, new role at BII for Soni and more
BioCentury | Apr 9, 2024
Discovery & Translation

AACR brings new modalities, new targets to glioblastoma

BioCentury identifies new CAR T cell designs, ADCs and other modalities, plus 37 preclinical targets for
BioCentury | Nov 8, 2022
Distillery Therapeutics

Tetravalent TREM2 agonist antibody for Alzheimer's

BioCentury | Feb 25, 2020
Distillery Therapeutics

Inhibiting necroptosis to treat ischemic stroke

BioCentury | Sep 26, 2017
Distillery Therapeutics

Neurology

BioCentury | Feb 10, 2017
Clinical News

CEVA101: Ph I data

BioCentury | Mar 10, 2016
Distillery Therapeutics

Therapeutics: Nicotinic acetylcholine receptor α7 (CHRNA7)

BioCentury | Feb 13, 2014
Distillery Therapeutics

Indication: Cancer

Items per page:
1 - 10 of 24